Bristol-Myers Squibb Company (NYSE:BMY) will host a teleconference on Tuesday, September 8 at 8 a.m. EDT (6 a.m. MDT) to review data presented at the 16th Annual World Conference on Lung Cancer (WCLC) in Denver, CO.
Company executives will provide an overview of data presented on our Immuno-Oncology portfolio at the meeting, and address inquiries from investors and analysts.
Investors and the general public are invited to listen to a live webcast of the call at http://investor.bms.com, by dialing U.S. toll-free (877) 201-0168 or international (647) 788-4901, confirmation code: 29586971. Materials related to the call will be available at the same website prior to the call. A replay of the call will be available beginning at 10:30 p.m. EDT on September 8 through 11:59 p.m. EDT on September 23. The replay can be accessed at http://investor.bms.com or by dialing U.S. toll-free (855) 859-2056 or international (404) 537-3406, confirmation code: 29586971.
